United States Últimas notícias

Yext (NYSE:YEXT) reported second quarter fiscal 2027 revenue of $111.1 million, alongside adjusted EBITDA of $34 million and annual recurring revenue of $440.8 million.

Helix Energy Solutions Group (NYSE:HLX) and Hornbeck Offshore Services completed their previously announced all-stock combination, creating an integrated offshore services company operating under the Hornbeck Offshore Services name.

Korn Ferry (NYSE:KFY) completed its acquisition of UK-headquartered AMS from OMERS Private Equity, adding technology-enabled talent solutions to its global consulting platform.

Wei Li, BlackRock Global Chief Investment Strategist, joins Bloomberg's Vonnie Quinn on "Bloomberg Brief" to discuss the risks and income opportunities within the fixed income market.

Kazia Therapeutics (NASDAQ:KZIA) reported preclinical data showing its PI3K/mTOR inhibitor paxalisib reduced tumor burden by 52% in an MSS/pMMR colorectal cancer model.

Comstock Resources (NYSE:CRK) signed a binding letter of intent with SOCAR for the sale of non-operated working interests in its Legacy and Western Haynesville upstream assets and a 15% stake in Pinnacle Gas Services for $1.65 billion in cash.

Krishna Guha, vice chair and head of central bank strategy at Evercore ISI, sees inflation, oil prices, and bond yields being of more importance to the Federal Reserve than US jobs data in determining whether to raise interest rates at this month's meeting.

Descartes Systems Group (NASDAQ:DSGX) acquired Extensiv, a California-based provider of AI-enabled warehouse management and omnichannel fulfillment solutions, for approximately $120 million.

Kazia Therapeutics (NASDAQ:KZIA) reported preclinical results showing its PI3K/mTOR inhibitor paxalisib produced antitumor activity when combined with standard therapies in HR+/HER2- breast cancer models.

RedHill Biopharma (NASDAQ:RDHL) acquired exclusive global commercialization rights to Rebyota and exclusive U.S. rights to Clenpiq from Ferring Pharmaceuticals in a transaction focused on expanding its gastrointestinal business.

Adicet Bio (NASDAQ:ACET) completed the last patient visit for the planned Phase 1 safety and efficacy analysis of prulacabtagene leucel (prula-cel) in patients with systemic lupus erythematosus with or without lupus nephritis.

Bunge Global (NYSE:BG) agreed to sell its two sugarcane mills in São Paulo, Brazil, to COFCO International as part of the company’s strategic business priorities.